Print

Lay Description

This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.

Category

IRB Number
20090478HU
NCT Number
NCT00736749

Eligibility

Eligible Ages
Between N/A and N/A
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • The patient must be enrolled on a frontline COG therapeutic trial for treatment of a primary malignancy;or the patient must have been enrolled on a COG (or Legacy Group) therapeutic or non-therapeutic trial targeted for long-term follow-up by ALTE05N1

    • Hodgkin lymphoma

      • CCG 5942
      • POG 9425
      • POG 9426
      • AHOD0031
      • AHOD1331
      • S1826 (COG patients only)

    • Brain tumor

      • A9961

    • Acute lymphoblastic leukemia

      • POG 9404

    • Osteosarcoma

      • POG 9754

    • Stem cell transplantation

      • ASCT0631D

    • Rhabdomyosarcoma

      • IRS-III
      • IRS-IV

    • Late Effects Protocols with Patients Eligible for Enrollment on ALTE05N1

      • ALTE15N1
      • ALTE16C1
    • Enrollment on ALTE05N1 must occur within 24 calendar months of the date the patient was enrolled on a frontline COG therapeutic trial; or patients previously enrolled on a COG (or Legacy Group) trial targeted for long term follow-up by ALTE05N1 may enroll on ALTE05N1 at any time
  • The patient must reside in the U.S. on the date of enrollment to ALTE05N1
  • All patients and/or their parents or legal guardians must sign a written informed consent
  • All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met

Exclusion Criteria

>

Study Design

Arm Groups

Study Contact

Virginia Diaz
210-562-9149
diazvr@uthscsa.edu

Jaclyn Hung
210-450-5358
hungj@uthscsa.edu

Principal Investigator
Shafqat Shah